Usa India Britain hospital covid-19 vaccine Government novavax reports Manufacturing Usa India Britain

Growing stock of unused COVID vaccines a financial risk for vaccine manufacturers

Reading now: 836
www.livemint.com

Driven by plummeting numbers of COVID cases across the world post-pandemic, several vaccine manufacturers are dealing with a slump in vaccine demand.

The low level of COVID cases is also encouraging the government to pause coming up with another booster dose. The falling demand for vaccines across western nations like the US, UK, etc, is a major concern for vaccine makers who are sitting over a large inventory of unused COVID vaccines.

Recently, a slump in vaccine demand forced Novavax to request the governments to come up with purchase commitments for their COVID-19 vaccine to help the biotech firm stay afloat amid collapsing demand for jabs, reported Financial Times in its report.

In India, Serum Institute of India announced to restart the manufacturing of Covishield in response to the rising COVID cases.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA